Human embryos successfully edited by Chinese researchers via CRISPR-Cas9

04/22/2015 - 00:00

Antonio Regalado


In an ethically charged first, Chinese researchers have used gene editing to modify human embryos obtained from an in-vitro fertilization clinic.

The 16-person scientific team, based at the Sun Yat-Sen University in Guangzhou, China, set out to see whether it could correct the gene defect that causes beta-thalassemia, a blood disease, by editing the DNA of fertilized eggs.

READ MORE ON MIT TECHNOLOGY REVIEW

Ref:   CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & Cell (2015) | DOI:10.​1007/​s13238-015-0153-5